| Systematic (IUPAC) name | |
|---|---|
| 1-ethyl-4-oxo-7-(phenylmethyl)-1,8-naphthyridine-3-carboxylic acid; | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Identifiers | |
| CAS number | 15180-02-6 |
| ATC code | None |
| PubChem | CID 2137 |
| ChemSpider | 2052 |
| UNII | RR302AR19Y |
| KEGG | D02897 |
| ChEMBL | CHEMBL35337 |
| Chemical data | |
| Formula | C18H16N2O3 |
| Mol. mass | 308.331 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Amfonelic acid (AFA; WIN 25,978; Oxaprozin) is a drug used in scientific studies. It was discovered while researchers were investigating novel antibiotics.[1]In studies it was found a potent and highly selective dopamine reuptake inhibitor (DRI) in rat brain preparations.[2][3] A study found a moderately long half-life of approximately 12 hours and a dopaminergic potency approximately 50 fold that of methylphenidate in rat brain preparations.[4]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)